Position in JNJ
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$5,345,560
+$102,078 QoQ
Shares Held
21,048
-1.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#1,566
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CHILTON CAPITAL MANAGEMENT LLC holds $189,707,778 across 12 Drug Manufacturers - General names. JNJ ranks #4 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
69,286 | $83,103,713 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
411,727 | $52,017,589 | |
| 3 | AZN |
Astrazeneca PLC
|
201,189 | $38,149,458 | |
| 4 | JNJ |
Johnson & Johnson
This page
|
21,048 | $5,345,560 | |
| 5 | MRK |
Merck & Co., Inc.
|
29,329 | $3,768,776 | |
| 6 | ABBV |
AbbVie Inc.
|
13,608 | $3,424,317 | |
| 7 | AMGN |
Amgen Inc
|
4,095 | $1,482,881 | |
| 8 | NVS |
Novartis AG
|
7,290 | $1,142,488 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,345,560 | 21,048 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $5,243,482 | 21,451 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $4,580,010 | 22,131 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $4,194,942 | 22,624 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $2,400,619 | 15,716 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $2,542,493 | 15,331 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $2,221,363 | 15,360 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $2,702,350 | 16,675 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $2,560,284 | 17,517 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $2,638,292 | 16,678 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $2,742,166 | 17,495 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $2,937,756 | 18,862 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $3,036,298 | 18,344 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,981,425 | 19,235 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $3,050,392 | 17,268 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,850,795 | 17,451 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,059,562 | 17,236 | Shares | Sole | 2022-08-16 | |
| 2022-03-31 | $2,961,690 | 16,711 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $3,026,741 | 17,693 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,863,395 | 17,730 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $2,555,941 | 15,515 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $2,249,458 | 13,687 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $2,210,874 | 14,048 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $2,047,546 | 13,753 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,960,100 | 13,938 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $1,934,167 | 14,750 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||